City
Epaper

Mankind Pharma files draft paper with SEBI for IPO

By ANI | Updated: September 16, 2022 22:15 IST

Pharmaceutical company Mankind Pharma Ltd, which is known for the brands like Manforce Condoms and Prega-News, has filed the draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) for IPO.

Open in App

Pharmaceutical company Mankind Pharma Ltd, which is known for the brands like Manforce Condoms and Prega-News, has filed the draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) for IPO.

The Initial public offering (IPO) of Mankind Pharma will comprise an offer for sale (OFS) of 40,058,844 (around 4 crore) equity shares by the company's promoters and existing shareholders.

The promoters of the company include Ramesh Juneja, Rajeev Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajeev Juneja Family Trust and Prem Sheetal Family Trust.

The offer for sale comprises up to 1 crore shares by promoter Juneja family, up to 2 crore shares by Capital International, up to 99.65 lakh by Beige, and up to 50,000 equity shares by Link Investment Trust.

The size of the IPO is estimated to be around Rs 7,500 crore. This will be among the largest ever IPO in the Indian pharma industry.

Mankind Pharma was incorporated in 1991. The company's popular brands include Prega-News pregnancy testing kits, Manforce condoms, Gas-O-Fast ayurvedic antacids and acne-treating medicine AcneStar.

Mankind Pharma operates 23 manufacturing facilities across India, including in the states of Himachal Pradesh, Sikkim, Rajasthan, Andhra Pradesh and Uttarakhand as of March 31, 2022.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Mankind pharma ltdRamesh junejaRajeev junejaSecurities And Exchange Board Of IndiaSecurities exchange board of india
Open in App

Related Stories

NationalSEBI Cracks Down on Stock Market Misleaders: 15,000 Sites and Influencers Banned

NationalAnil Ambani Reviewing SEBI Order Imposing Rs 25 Crore Fine and Five-Year Capital Markets Ban

MaharashtraSEBI required to act in public interest: Bombay HC raps regulatory body

InternationalSAT suspends SEBI order banning IIFL Securities from onboarding new clients for 2 years

InternationalChairman Emeritus and MD of large listed company diverted public money: SEBI reply to SAT in Zee matter

Business Realted Stories

BusinessDelhivery gets CCI approval for 99. 44 % stake in Ecom Express

BusinessDGCA gives clean chit to Air India’s Boeing 787 fleet amid thorough inspection

BusinessNo major safety concerns with Air India’s Boeing 787 fleet: DGCA

BusinessCBI, DFS, public sector banks hold key meeting in Bengaluru on fraud investigations

BusinessPM Modi’s outreach to diaspora spurs FDI flow into India